ATE179713T1 - Verfahren zur selektiven isolierung von beta-2'- desoxy-2'2'-difluorocytidin oder seiner salze - Google Patents

Verfahren zur selektiven isolierung von beta-2'- desoxy-2'2'-difluorocytidin oder seiner salze

Info

Publication number
ATE179713T1
ATE179713T1 AT94202041T AT94202041T ATE179713T1 AT E179713 T1 ATE179713 T1 AT E179713T1 AT 94202041 T AT94202041 T AT 94202041T AT 94202041 T AT94202041 T AT 94202041T AT E179713 T1 ATE179713 T1 AT E179713T1
Authority
AT
Austria
Prior art keywords
deoxy
difluorocytidiine
beta
salts
difluoronucleosides
Prior art date
Application number
AT94202041T
Other languages
English (en)
Inventor
Ta-Sen Chou
Perry Clark Heath
Lawrence Edward Patterson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE179713T1 publication Critical patent/ATE179713T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94202041T 1987-08-28 1988-08-22 Verfahren zur selektiven isolierung von beta-2'- desoxy-2'2'-difluorocytidin oder seiner salze ATE179713T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9072587A 1987-08-28 1987-08-28

Publications (1)

Publication Number Publication Date
ATE179713T1 true ATE179713T1 (de) 1999-05-15

Family

ID=22224017

Family Applications (4)

Application Number Title Priority Date Filing Date
AT95201845T ATE217009T1 (de) 1987-08-28 1988-08-22 Stereoselektives verfahren zur herstellung von geschützten 2',2'-difluorlactonen
AT88307750T ATE164847T1 (de) 1987-08-28 1988-08-22 Verfahren zur herstellung von zwischenverbindungen verwendbar in der herstellung von 2',2'-difluoronucleosiden
AT94202041T ATE179713T1 (de) 1987-08-28 1988-08-22 Verfahren zur selektiven isolierung von beta-2'- desoxy-2'2'-difluorocytidin oder seiner salze
AT95201846T ATE202113T1 (de) 1987-08-28 1988-08-22 Verfahren zur herstellung von 2'-deoxy-2',2'- difluornukleosiden

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT95201845T ATE217009T1 (de) 1987-08-28 1988-08-22 Stereoselektives verfahren zur herstellung von geschützten 2',2'-difluorlactonen
AT88307750T ATE164847T1 (de) 1987-08-28 1988-08-22 Verfahren zur herstellung von zwischenverbindungen verwendbar in der herstellung von 2',2'-difluoronucleosiden

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT95201846T ATE202113T1 (de) 1987-08-28 1988-08-22 Verfahren zur herstellung von 2'-deoxy-2',2'- difluornukleosiden

Country Status (11)

Country Link
EP (4) EP0630905B1 (de)
JP (5) JP2738540B2 (de)
KR (1) KR970002659B1 (de)
AT (4) ATE217009T1 (de)
CA (1) CA1324128C (de)
DE (4) DE3856158T2 (de)
ES (4) ES2131152T3 (de)
GR (1) GR3026611T3 (de)
HU (3) HU206886B (de)
IE (1) IE81131B1 (de)
IL (1) IL87517A (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2012129A1 (en) * 1989-03-20 1990-09-20 Ramakrishnan Nagarajan Recovery of difluoro sugar
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
US5256797A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for separating 2-deoxy-2,2-difluoro-D-ribofuranosyl alkylsulfonate anomers
US5401861A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
US5256798A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
US5252756A (en) * 1992-06-22 1993-10-12 Eli Lilly And Company Process for preparing beta-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl-arylsulfonates
US5559222A (en) * 1995-02-03 1996-09-24 Eli Lilly And Company Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
JP2000501738A (ja) 1995-12-13 2000-02-15 イーライ・リリー・アンド・カンパニー α,α―ジフルオロ―β―ヒドロキシチオールエステル及びその合成
KR100578616B1 (ko) * 2004-07-23 2006-05-10 한미약품 주식회사 D-에리트로-2,2-다이플루오로-2-데옥시-1-옥소라이보스화합물의 제조방법
WO2007049294A1 (en) * 2005-10-28 2007-05-03 Arch Pharmalabs Limited An improved process for preparation of gemcitabine hydrochloride.
EP1960378A4 (de) * 2005-12-14 2011-05-25 Dong A Pharm Co Ltd Verfahren zur herstellung von 2',2'-difluornukleosiden und zwischenprodukte
KR100741310B1 (ko) * 2006-08-01 2007-08-01 (주) 유일팜테크 젬시타빈의 합성에 유용한 신규한나프탈렌-2-카르복실레이트 유도체와 그의 제조방법
EP2139884B1 (de) * 2007-03-23 2013-12-04 Dongwoo Syntech Co., Ltd. Verfahren zur herstellung von 2'-desoxy-2',2'-difluorcytidin
NZ590058A (en) * 2008-06-12 2012-08-31 Scinopharm Taiwan Ltd Crystalline polymorphs of gemcitabine base
GB0812895D0 (en) 2008-07-15 2008-08-20 Glycom As Crystalline carbohydrate derivative
CN121949418B (zh) * 2026-04-01 2026-07-28 山东安弘制药有限公司 一种盐酸吉西他滨的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
DE3587500T2 (de) * 1984-12-04 1993-12-16 Lilly Co Eli Tumorbehandlung bei Säugetieren.
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents

Also Published As

Publication number Publication date
ES2157289T3 (es) 2001-08-16
JPH1081696A (ja) 1998-03-31
DE3856330D1 (de) 1999-06-10
DE3856477D1 (de) 2001-07-19
EP0306190A2 (de) 1989-03-08
EP0688783B1 (de) 2001-06-13
ES2176279T3 (es) 2002-12-01
HU906268D0 (en) 1991-03-28
HUT47590A (en) 1989-03-28
EP0688783A1 (de) 1995-12-27
IL87517A0 (en) 1989-01-31
EP0306190A3 (de) 1991-11-21
ES2131152T3 (es) 1999-07-16
KR970002659B1 (ko) 1997-03-07
ATE164847T1 (de) 1998-04-15
KR890003794A (ko) 1989-04-18
DE3856158D1 (de) 1998-05-14
HU9201768D0 (en) 1992-08-28
JPH1072457A (ja) 1998-03-17
JP2899577B2 (ja) 1999-06-02
JP2738540B2 (ja) 1998-04-08
DE3856477T2 (de) 2001-11-08
GR3026611T3 (en) 1998-07-31
JPS6471894A (en) 1989-03-16
ATE217009T1 (de) 2002-05-15
EP0688782A1 (de) 1995-12-27
DE3856527D1 (de) 2002-06-06
HU206886B (en) 1993-01-28
EP0306190B1 (de) 1998-04-08
HU202249B (en) 1991-02-28
DE3856527T2 (de) 2002-10-31
ATE202113T1 (de) 2001-06-15
JP2777359B2 (ja) 1998-07-16
IE81131B1 (en) 2000-03-22
IE882608L (en) 1989-02-28
IL87517A (en) 1993-05-13
DE3856158T2 (de) 1998-08-20
JP2810034B2 (ja) 1998-10-15
DE3856330T2 (de) 1999-09-30
EP0630905A1 (de) 1994-12-28
EP0630905B1 (de) 1999-05-06
EP0688782B1 (de) 2002-05-02
JPH1072484A (ja) 1998-03-17
JPH1072483A (ja) 1998-03-17
JP2899576B2 (ja) 1999-06-02
CA1324128C (en) 1993-11-09
ES2113845T3 (es) 1998-05-16

Similar Documents

Publication Publication Date Title
DE3856330D1 (de) Verfahren zur selektiven Isolierung von beta-2'-desoxy-2'2'-difluorocytidin oder seiner Salze
ATA245485A (de) Verfahren zur herstellung von neuen dihydropyridincarbonsaeure-derivaten
MY102581A (en) Process for production of avermectins and cultures therefor
DE3680800D1 (de) Verfahren zur herstellung von (6r)-tetrahydro-l-biopterin.
DE69839306D1 (de) Verfahren zur herstellung und reinigung von 9-nitro-20-camptothecin
DE3784988D1 (de) Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686.
FI884250L (fi) Menetelmä suurien levymäisten, neulamaisten kipsikiteiden valmistamiseksi
AT359191B (de) Verfahren zur herstellung von neuen derivaten des daunorubicins
DE3582368D1 (de) Verfahren zur herstellung von epoxyden mittels mikroorganismen.
AT354834B (de) Verfahren zur verbesserung der naehrstoff- verwertung und des wachstums bei wiederkaeuern und kaninchen sowie futter- oder futterzu- satzmittel zur durchfuehrung des verfahrens
DE3785266D1 (de) Stamm zur massenproduktion von epsilon-poly-l-lysin, methode, um diesen stamm zu gebrauchen, und methode zur herstellung von epsilon-poly-l-lysin.
DE3782169D1 (de) Verfahren zur herstellung von antibiotica 10381b.
DE3878580D1 (de) Verfahren zur herstellung von kristallinen explosivstoffen.
ATA185987A (de) Verfahren zur hestellung von neuen derivaten von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5- benzoxazonin (bzw. -1,4-benzoxazonin)
ATA118987A (de) Kominiertes verfahren zur termischen und chemischen behandlung von lignocellulosehaltiger biomasse und zur gewinnung von furfural
IT1206247B (it) Metodo e composizione per migliorare il regime di crescita di animali
RU93032993A (ru) Состав для обработки скважины и/или призабойной зоны пласта и способ обработки скважины и/или призабойной зоны пласта
ATE118551T1 (de) Verfahren zur herstellung von s-2,2-r1,r2-1,3- dioxolan-4-methanol.
DE69225610D1 (de) Verfahren zur herstellung von avermectin und kulturen dafür
ATA223587A (de) Verfahren zur herstellung von cis-3-hydroxyprolin durch trans-cis-isomerisierung von trans-3hydroxyprolin
DE3867339D1 (de) Verfahren zur herstellung von salzen des aminomalonsaeuredinitrils.
ATE58140T1 (de) Verfahren zur herstellung eines lactons.
ATA464080A (de) Verfahren zur herstellung von neuen o-substi- tuierten derivaten des (+)-cyanidan-3-ols und deren salzen
IT1209488B (it) Destrutturizzati. procedimento per la produzione di substrati cellulosici
AT378203B (de) Verfahren zur herstellung von glucoseisomerase

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time